Single Tissue Samples from Head and Neck Squamous Cell Carcinomas are Representative Regarding the Entire Tumor’s Chemosensitivity to Cisplatin and Docetaxel

Publisher： Karger

E-ISSN： 2296-5262|32|5|264-272

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.32, Iss.5, 2009-04, pp. : 264-272

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Molecular Biologic Characteristics of Seven New Cell Lines of Squamous Cell Carcinomas of the Head and Neck and Comparison to Fresh Tumor Tissue

By  

Oncology, Vol. 65, Iss. 1, 2003-07 ,pp. : 60-71

Karger

Access to resources Recommend Favorite

Phase II Study with Docetaxel and Cisplatin in the Treatment of Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck

By  

Oncology, Vol. 63, Iss. 2, 2002-09 ,pp. : 145-150

Karger

Access to resources Recommend Favorite

Prediction of Chemosensitivity Using Multigene Analysis in Head and Neck Squamous Cell Carcinoma

By  

Oncology, Vol. 73, Iss. 1-2, 2008-03 ,pp. : 104-111

Karger

Access to resources Recommend Favorite

RASSF1A and ERCC1 Expression Levels Might Be Predictive of Prognosis in Advanced, Recurrent, and Metastatic Squamous Cell Carcinoma of the Head and Neck Treated with Docetaxel and Cisplatin

By  

Oncology Research and Treatment, Vol. 35, Iss. 11, 2012-10 ,pp. : 673-682

Karger

Access to resources Recommend Favorite

Liver Metastases from Head and Neck Squamous Cell Carcinomas: Radiological and Biological Features

By  

Oncology Research and Treatment, Vol. 27, Iss. 2, 2004-05 ,pp. : 157-160

Karger

Access to resources Recommend Favorite